Sound Shore Management’s Novartis NVS Stock Holding History

Sound Shore Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,064,485	Closed	-$171M	–	43
2014 Q4	$171M	Buy	2,064,485 +148,013	+8%	+$12.3M	2.7%	12
2014 Q3	$162M	Buy	1,916,472 +306,217	+19%	+$24.8M	2.6%	17
2014 Q2	$131M	Sell	1,610,255 -88,909	-5%	-$6.99M	2.12%	36
2014 Q1	$129M	Sell	1,699,164 -132,621	-7%	-$9.66M	2.23%	26
2013 Q4	$132M	Sell	1,831,785 -19,294	-1%	-$1.34M	2.22%	27
2013 Q3	$127M	Sell	1,851,079 -60,370	-3%	-$3.99M	2.37%	22
2013 Q2	$121M	Buy	+1,911,449	New	+$124M	2.36%	27

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sound Shore Management's NVS Position: Q1 2015 in Review

Sound Shore Management sold out of Novartis (NVS) in Q1 2015, closing a stake of 2,064,485 shares — an estimated $171M sold.

Sound Shore Management first reported a position in NVS in Q2 2013 and held it in 7 quarters. The position peaked at $171M in Q4 2014. 940 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

Sound Shore Management reported no remaining Novartis position as of Q1 2015 after selling out during the quarter.
Sound Shore Management sold 2,064,485 Novartis shares in Q1 2015, an estimated $171M.
Sound Shore Management first reported a position in Novartis in Q2 2013 and held it in 7 quarters.
Sound Shore Management's Novartis position peaked at $171M in Q4 2014.
940 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Sound Shore Management's 13F filing for Q1 2015, filed 8 May 2015.